Mar 13, 2023 / 12:00PM GMT
Justin Kim Oppenheimer-Analyst
Great. So good morning, everyone, thanks for joining us today for Oppenheimer's Annual Healthcare Conference, the Virtual Edition. I'm Justin Kim, one of the research analysts at Oppenheimer, and I have the pleasure of opening the conference with one of my covered companies, Pharvaris, who are working on the hereditary angioedema space. Today, we have the Pharvaris team, Berndt Modig and Dr. Morgan Conn, to talk with us about the company and its ongoings. Thanks for joining us, everyone.
Morgan Conn Pharvaris N.V.-Chief Business Officer
Thank you, Justin.
Berndt Modig Pharvaris N.V.-CEO - Director
Yeah. Thanks, Justin, good to be here, and thanks for the invitation. So in the next 30 minutes, we'll look forward to discussion and questions also -- I think more of a fireside chat format with Justin about Pharvaris, and just as -- I'm giving a quick intro -- I mean, obviously, we're a public company, so I'll be making some forward-looking statements, and that
Pharvaris NV at Oppenheimer Healthcare Conference (Virtual) Transcript
Mar 13, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers